Array BioPharma and Amgen Partner in Type 2 Diabetes Array BioPharma Inc.

Our proprietary drug development pipeline includes clinical applicants that can regulate therapeutically important focus on proteins and are aimed at significant unmet medical demands. Furthermore, leading pharmaceutical and biotechnology businesses collaborate with Array to discover and develop drug applicants across a broad range of therapeutic areas. For more information on Array, please go to About Amgen Amgen discovers, develops, delivers and manufactures innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing effective and safe medicines from lab, to manufacturing facility, to individual. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight cancer, kidney disease, rheumatoid arthritis, and other serious ailments.Lochs, a gastroenterologist and business lead author of the research says that when both patients were put on a diet without sorbitol, they gained fat and their diarrhea disappeared. The researchers warn that sorbitol is also a laxative which might lead to chronic diarrhea and ‘possibly dangerous weight reduction.’ They state any investigation of unexplained weight loss will include detailed dietary history with regard to foods containing sorbitol. Sorbitol which is called E420 also, is a sugar alcoholic beverages and a mass sweetener found in numerous foods particularly diet foods, diet drinks and ice cream and sugar-free nicotine gum.